Chembio Diagnostics Inc Stock CEMI Share Price Today, News and Discussion

Below are the latest news stories about CHEMBIO DIAGNOSTICS INC that investors may wish to consider to help them evaluate CEMI as an investment opportunity. NEOG, CLVS, and ENDP are the stocks whose asset turnover ratios are most correlated with CEMI. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android. Biosynex has entered into a deal with Chembio Diagnostics under which Biosynex will acquire Chembio in an all-cash transaction valued at $17.2M.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2023.

Measures how much net income or profit is generated as a percentage of revenue.

CEMI Valuation Summary

Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for CEMI is recording 1.08 at the time of this writing. Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are equity securities that have been issued pursuant to Regulation A of the Securities Act of (“Regulation A”). These investments are speculative, involve substantial risks , and are not FDIC or SIPC insured. Alternative Assets purchased on the Public platform are not held in an Open to the Public Investing brokerage account and are self-custodied by the purchaser. The issuers of these securities may be an affiliate of Public, and Public may earn fees when you purchase or sell Alternative Assets.

Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Hauppauge, NY. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years. The volatility of CHEMBIO DIAGNOSTICS INC’s share price is greater than that of 92.76% US stocks with at least 200 days of trading history. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.

Chembio Diagnostics Inc Past Events

Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.

• Real-time analyst ratings, insider transactions, earnings data, and more.
• The company was founded in 1985 and is headquartered in Hauppauge, NY.
• Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC.
• U.S. Treasuries (“T-Bill“) investing services on the Public Platform are offered by Jiko Securities, Inc. (“JSI”), a registered broker-dealer and member of FINRA & SIPC.
• According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.3400, with a change in the price was noted +0.10.

There may be delays, omissions, or inaccuracies in the Information. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score.

The technique has proven to be very useful for finding positive surprises. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Chembio Diagnostics’ stock was trading at $0.2197 at the beginning of the year. Since then, CEMI stock has increased by 50.2% and is now trading at $0.33.

Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. The company is scheduled to release its next quarterly earnings announcement on Friday, March 17th 2023. The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.CEMI has a Quality Grade of F, ranking ahead of 4.04% of graded US stocks. Over the past 33 months, CEMI’s revenue has gone up $25,287,696.The table below shows CEMI’s growth in key financial areas .

CEMI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chembio Diagnostics, Inc. Is Fair to Shareholders

The major emphasis of this platform is to present, the most practical recommendation for public and private capital sharing, both in the form of updates and detailed analysis. Raw Stochastic average of Chembio Diagnostics Inc. in the period of last 50 days is set at 71.36%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 15.10%. In the last 20 days, the company’s Stochastic %K was 56.82% and its Stochastic %D was recorded 67.62%. © 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with intertrader review is a scam or legit forex broker the SEC has been qualified by the SEC. An indication of interest to purchase securities involves no obligation or commitment of any kind. Discuss news and analysts’ price predictions with the investor community. CEMI stock is soaring today after the company announced the commercial launch of a rapid Covid-19 test that was met with significant optimism.

Key Earnings Data

Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The company was founded in 1985 and is based in Medford, New York. Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically during the Regular Trading Hours. Keep in mind that other fees such as regulatory fees, Premium subscription fees, commissions on trades during extended trading hours, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

When it comes to the year-to-date metrics, the Chembio Diagnostics Inc. recorded performance in the market was 78.38%, having the revenues showcasing 18.79% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 14.39M, as it employees total of 337 workers. According to 6 analysts, the average rating for CEMI stock is “Sell.” The 12-month stock price forecast is $8.16, which is an increase of 2,372.73% from the latest price. NEW YORK — Chembio Diagnostics’ stock shot up 18% in premarket trade Monday, after the company said it partnered with Integrated BioTherapeutics to develop diagnostic tests for the Ebola virus. Shares of Chembio Diagnostics Inc. skyrocketed 63.8% on record volume in afternoon trading Monday, to pace all gainers listed on major U.S. exchanges, in the wake of the point-of-care diagnostics company’s announcement of…

Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results

JSI uses funds from your Treasury Account to purchase T-bills in increments of $100 “par value” (the T-bill’s value at maturity). The value of T-bills fluctuate and investors https://day-trading.info/ may receive more or less than their original investments if sold prior to maturity. T-bills are subject to price change and availability – yield is subject to change.

Market Cap is calculated by multiplying the number of shares outstanding by the stock’s price. To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded.Dividend YieldA company’s dividend expressed as a percentage of its current stock price.

With a price/sales ratio of 0.2, CHEMBIO DIAGNOSTICS INC has a higher such ratio than merely 6.08% of stocks in our set. We have 9 different ratings for every stock to help you appreciate its future potential. International health officials vowed after West Africa’s Ebola crisis to be better armed for the next epidemic with vaccines, drugs and diagnostic tests. Now the next one–Zika–is here and in an echo of Ebola, researchers… What analysts recommend for CEMI stock, on a scale from 1 to 5. Volatility profiles based on trailing-three-year calculations of the standard deviation of service investment returns.

GET POWR RATINGS… FREE!

A hold rating indicates that analysts believe investors should maintain any existing positions they have in CEMI, but not buy additional shares or sell existing shares. Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity.